Supplementary Figure S2 from Dual Inhibition of NOX2 and Receptor Tyrosine Kinase by BJ-1301 Enhances Anticancer Therapy Efficacy via Suppression of Autocrine-Stimulatory Factors in Lung Cancer
Year: 2023
Type: supplementary-materials
Abstract: No change in intracellular signalling pathways and ROS production by BJ-1301 alone treatment. HUVECs were treated with indicated concentration of BJ-1301. Protein extracts were examined for phosphorylation of MAPKs (A) and NF-kB nuclear translocation (B). ROS production (C) was measured by using an inverted fluorescent microscope (TE2000-U; Nikon, Japan).
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362623786